Yan H - Search Results

1

Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes.

Duan XF, Wu YL, Xu HZ, Zhao M, Zhuang HY, Wang XD, Yan H, Chen GQ. Duan XF, et al. Among authors: yan h. Chem Biol Interact. 2010 Jan 5;183(1):222-30. doi: 10.1016/j.cbi.2009.09.012. Chem Biol Interact. 2010. PMID: 19781537

2

Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.

Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, Zhang WH, Peng CH, Zhang SD, Li HW, Chen GQ. Yu Y, et al. Among authors: yan h. Oncology. 2005;68(1):79-86. doi: 10.1159/000084824. Epub 2005 Apr 8. Oncology. 2005. PMID: 15864000

3

Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.

Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ. Yan H, et al. Haematologica. 2005 Dec;90(12):1607-16. Haematologica. 2005. PMID: 16330433

4

NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells.

Chen S, Han YH, Zheng Y, Zhao M, Yan H, Zhao Q, Chen GQ, Li D. Chen S, et al. Among authors: yan h. Leuk Res. 2009 Aug;33(8):1108-13. doi: 10.1016/j.leukres.2008.10.016. Epub 2008 Nov 28. Leuk Res. 2009. PMID: 19046768

5

Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells.

Gu ZM, Wu YL, Zhou MY, Liu CX, Xu HZ, Yan H, Zhao Y, Huang Y, Sun HD, Chen GQ. Gu ZM, et al. Among authors: yan h. Blood. 2010 Dec 9;116(24):5289-97. doi: 10.1182/blood-2010-02-267963. Epub 2010 Aug 25. Blood. 2010. PMID: 20739655 Free article.

6

Autophagy inhibition enhances isobavachalcone-induced cell death in multiple myeloma cells.

Zhao S, Ma CM, Liu CX, Wei W, Sun Y, Yan H, Wu YL. Zhao S, et al. Among authors: yan h. Int J Mol Med. 2012 Oct;30(4):939-44. doi: 10.3892/ijmm.2012.1066. Epub 2012 Jul 16. Int J Mol Med. 2012. PMID: 22824846

7

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.

Wei W, Huang H, Zhao S, Liu W, Liu CX, Chen L, Li JM, Wu YL, Yan H. Wei W, et al. Among authors: yan h. Apoptosis. 2013 Sep;18(9):1060-70. doi: 10.1007/s10495-013-0854-2. Apoptosis. 2013. PMID: 23613107

8

Targeting poly (ADP-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells.

Huang H, Cao Y, Wei W, Liu W, Lu SY, Chen YB, Wang Y, Yan H, Wu YL. Huang H, et al. Among authors: yan h. PLoS One. 2013 Jun 7;8(6):e66130. doi: 10.1371/journal.pone.0066130. Print 2013. PLoS One. 2013. PMID: 23762475 Free PMC article.

9

Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.

Xu W, Wei W, Yu Q, Wu C, Ye C, Wu Y, Yan H. Xu W, et al. Among authors: yan h. Mol Med Rep. 2014 Sep;10(3):1519-24. doi: 10.3892/mmr.2014.2333. Epub 2014 Jun 16. Mol Med Rep. 2014. PMID: 24939418

10

Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling.

Cao Y, Wei W, Zhang N, Yu Q, Xu WB, Yu WJ, Chen GQ, Wu YL, Yan H. Cao Y, et al. Among authors: yan h. BMC Cancer. 2015 Apr 10;15:248. doi: 10.1186/s12885-015-1219-8. BMC Cancer. 2015. PMID: 25886043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,664 results

Search Page

Filters